Barbara Burtness, MD
Advertisement
Articles by Barbara Burtness, MD
Advertisement
Latest Updated Articles
Dr. Burtness on Ongoing Trials of Immunotherapy in Head and Neck CancerPublished: September 21st 2016 | Updated:
Dr. Burtness on Immunotherapy and Chemotherapy in Head and Neck CancerPublished: October 12th 2016 | Updated:
Dr. Burtness on the Use of Immunotherapy After Chemoradiation in Head and Neck CancerPublished: December 15th 2016 | Updated:
Dr. Burtness on Treatment Approaches in HPV-Positive Head and Neck CancerPublished: December 27th 2016 | Updated:
Dr. Burtness on Evolution of Molecular Testing in Head and Neck CancerPublished: May 3rd 2017 | Updated:
Dr. Burtness on Immunotherapy and Radioresistance in Head and Neck CancerPublished: July 19th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5